|
Volumn 109, Issue 6, 2002, Pages
|
Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIASTHMATIC AGENT;
BECLOMETASONE;
BUDESONIDE;
CHLOROFLUOROCARBON;
FLUORINATED HYDROCARBON;
NORFLURANE;
PROPELLANT;
ARTICLE;
ASTHMA;
CHEMISTRY;
CHILD;
CHILD DEVELOPMENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
FEMALE;
GROWTH;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
LUNG FUNCTION TEST;
MALE;
METHODOLOGY;
MULTICENTER STUDY;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
AEROSOL PROPELLANTS;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
BUDESONIDE;
CHEMISTRY, PHARMACEUTICAL;
CHILD;
CHILD DEVELOPMENT;
CHILD, PRESCHOOL;
CHLOROFLUOROCARBONS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GROWTH;
HUMANS;
HYDROCARBONS, FLUORINATED;
MALE;
RESPIRATORY FUNCTION TESTS;
TREATMENT OUTCOME;
|
EID: 0036595473
PISSN: None
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.109.6.e92 Document Type: Article |
Times cited : (65)
|
References (0)
|